Research Feed
CONMED Q4 2025 Beat Masked by Mechanical Guidance Step-Down; AirSeal Penetration at 6-7% of 3M+ Procedure Market
CONMED reported Q4 2025 EPS of $1.43, beating consensus of $1.32, with orthopedics revenue up 12.1% and supply chain backorders at a three-year low. Despite the operational beat, management guided 2026 EPS to $4.30-$4.45, down from $4.59, attributing the decline entirely to the GI portfolio exit ($0